Jupiven Pharmaceuticals Private Limited, a active private limited company, was established on 12 August 2010 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232DL2010PTC206990. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.60 M and a paid-up capital of ₹1.60 M.
It upholds a compliant status. Employing 11 professional, Its leadership includes Sarojani Tiku (Director), Subhash Tikoo (Director). Past directors included Chitesh Tiku, Mehrajuddin Khan. It holds ₹1.40 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at L- 199-B, Pkt-L, Dilshad Garden, Delhi- 110095, Delhi, Delhi, 110095.
U24232DL2010PTC206990
206990
12 August 2010
₹1.60 M
₹1.60 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Jupiven Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sarojani Tiku | Director | 12 Aug 2010 | Current |
| Subhash Tikoo | Director | 01 Aug 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 15 Apr 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jupiven Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 61.21% increase. The company also saw a substantial improvement in profitability, with a 220.88% increase in profit. The company's net worth Soared by an impressive increase of 125.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Jupiven Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹14,001,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2023 | Others | ₹7.00 M | Open |
| 01 Aug 2023 | Hdfc Bank Limited | ₹2.00 M | Open |
| 07 Dec 2021 | Others | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Jupiven Pharmaceuticals has a workforce of 11 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jupiven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jupiven Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jupiven Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Jupiven Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with Others amounted to Rs. 7.00 M with Charge ID 100806717 was registered on 18 Oct 2023. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 2.00 M with Charge ID 100805399 was registered on 01 Aug 2023. was recorded as a recent event.
Progress on A charge with Others of Rs. 5.00 M registered on 07 Dec 2021 with Charge ID 100520289 was modified on 19 Dec 2022. was documented.
A charge with Others amounted to Rs. 5.00 M with Charge ID 100520289 was registered on 07 Dec 2021. was recorded as a recent event.
The CIN of Jupiven Pharmaceuticals Private Limited is U24232DL2010PTC206990.
Jupiven Pharmaceuticals Private Limited is headquartered at L- 199-B, Pkt-L, Dilshad Garden, Delhi- 110095, Delhi, Delhi, 110095.
Jupiven Pharmaceuticals Private Limited was incorporated on 12 August 2010.
The current directors of Jupiven Pharmaceuticals Private Limited are
The primary industry of Jupiven Pharmaceuticals Private Limited is Trade.
Jupiven Pharmaceuticals Private Limited is unlisted.
The authorized capital of Jupiven Pharmaceuticals Private Limited is ₹1.60 M, and the paid-up capital is ₹1.60 M.
The compliance status of Jupiven Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX